Lormetazepam in oral solution: a formulation at risk of high-dose use.

Cosci, Fiammetta; Nardi, Antonio Egidio; Starcevic, Vladan; Chouinard, Guy; Balon, Richard

Cosci, Fiammetta; Nardi, Antonio Egidio; Starcevic, Vladan; Chouinard, Guy; Balon, Richard.

Afiliación

Cosci F; Department of Health Sciences, University of Florence, via di San Salvi, 12, 50135, Florence, Italy. fiammetta.cosci@unifi.it.
Nardi AE; Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, The Netherlands. fiammetta.cosci@unifi.it.
Starcevic V; Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Chouinard G; Faculty of Medicine and Health, Sydney Medical School, Nepean Clinical School, University of Sydney, Sydney, Australia.
Balon R; Clinical Pharmacology and Toxicology Program, McGill University and Mental Health Institute of Montreal Fernand Seguin Research Centre, Montreal, Canada.

Intern Emerg Med ; 14(8): 1203-1204, 2019 11.

Article en En | MEDLINE | ID: mdl-31270679

Asunto(s)

Benzodiazepinas; Lorazepam; Humanos; Lorazepam/análogos & derivados

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Benzodiazepinas / Lorazepam Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Intern Emerg Med Asunto de la revista: MEDICINA DE EMERGENCIA / MEDICINA INTERNA Año: 2019 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Italia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google